Question

I am a breastfeeding mother and i want to know if it is safe to use Azacitidine? Is Azacitidine safe for nursing mother and child? Does Azacitidine extracts into breast milk? Does Azacitidine has any long term or short term side effects on infants? Can Azacitidine influence milk supply or can Azacitidine decrease milk supply in lactating mothers?

Answer by DrLact: About Azacitidine usage in lactation

Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. It might be possible to breastfeed safely during intermittent azacitidine therapy with an appropriate period of breastfeeding abstinence; the manufacturer recommends an abstinence period of 1 week after the last dose. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[1] Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.[2]

Azacitidine Possible Effects in Breastfeeding

A telephone follow-up study was conducted on 74 women who received cancer chemotherapy at one center during the second or third trimester of pregnancy to determine if they were successful at breastfeeding postpartum. Only 34% of the women were able to exclusively breastfeed their infants, and 66% of the women reported experiencing breastfeeding difficulties. This was in comparison to a 91% breastfeeding success rate in 22 other mothers diagnosed during pregnancy, but not treated with chemotherapy. Other statistically significant correlations included: 1. mothers with breastfeeding difficulties had an average of 5.5 cycles of chemotherapy compared with 3.8 cycles among mothers who had no difficulties; and 2. mothers with breastfeeding difficulties received their first cycle of chemotherapy on average 3.4 weeks earlier in pregnancy. Of the 9 women who received a fluorouracil-containing regimen, 8 had breastfeeding difficulties.[2]

Alternate Drugs

Fluorouracil(Dangerous)
Thioguanine(Dangerous)
Gemcitabine(Dangerous)
Capecitabine(Dangerous)
Paclitaxel(Dangerous)
Bleomycin(Dangerous)
Fluorouracil(Dangerous)
Vinorelbine(Dangerous)
Dacarbazine(Dangerous)
Alemtuzumab(Low Risk)
Vincristine(Dangerous)
Cladribine(Dangerous)
Rituximab(Low Risk)
Letrozole(Dangerous)
Tamoxifen(Dangerous)
Docetaxel(Dangerous)
Exemestane(Dangerous)
Thioguanine(Dangerous)
Mitoxantrone(Dangerous)
Gemcitabine(Dangerous)
Bevacizumab(Low Risk)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Hydroxyurea(Low Risk)
Etoposide(Dangerous)
Dactinomycin(Dangerous)
Doxorubicin(Dangerous)
Trastuzumab(Unsafe)
Cyclophosphamide(Dangerous)
Ipilimumab(Unsafe)
Cisplatin(Unsafe)
Imatinib(Unsafe)
Cetuximab(Unsafe)
Busulfan(Dangerous)
Nivolumab(Unsafe)
Erlotinib(Unsafe)
Carboplatin(Dangerous)
Vinblastine(Dangerous)
Gemcitabine(Dangerous)
Orlistat(Low Risk)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Erlotinib(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.